Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Henning Friis Andersen"'
Publikováno v:
New England journal of medicine, 363(19), 1791-1800. Massachussetts Medical Society
Background: The use of recombinant activated factor VII (rFVIIa) on an off-label basis to treat life-threatening bleeding has been associated with a perceived increased risk of thromboembolic complications. However, data from placebo-controlled trial
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 24:138-145
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and delaying disease worsening is a relevant treatment outcome. Methods: Data from 6 randomized, double-blind, placebo-controlled, 6-month studies were pooled and a su
Publikováno v:
The International Journal of Neuropsychopharmacology. 7:283-290
In continuation of a previous psychometric analysis of dose-response data for citalopram in depression, the corresponding study data for escitalopram is of interest, since escitalopram is the active enantiomer of citalopram and because citalopram was
Autor:
Frank V. McL. Booth, Peter Skov Olsen, Ravi Gill, Henning Friis Andersen, Nancy A. Nussmeier, Christian M. Jespersen, Jerrold H. Levy
Publikováno v:
Thrombosis and haemostasis. 102(4)
SummaryBleeding following cardiac surgery involving cardiopulmonary bypass (CPB) remains a major concern. Coagulation factor XIII (FXIII) functions as a clot-stabilising factor by cross-linking fibrin. Low post-operative levels of FXIII correlate wit